"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
Descriptor ID |
D011379
|
MeSH Number(s) |
E01.789
|
Concept/Terms |
Prognostic Factors- Prognostic Factors
- Factor, Prognostic
- Factors, Prognostic
- Prognostic Factor
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 23 | 23 |
1995 | 0 | 22 | 22 |
1996 | 0 | 26 | 26 |
1997 | 0 | 22 | 22 |
1998 | 0 | 30 | 30 |
1999 | 0 | 35 | 35 |
2000 | 0 | 55 | 55 |
2001 | 0 | 32 | 32 |
2002 | 0 | 29 | 29 |
2003 | 1 | 52 | 53 |
2004 | 0 | 56 | 56 |
2005 | 0 | 64 | 64 |
2006 | 0 | 47 | 47 |
2007 | 0 | 76 | 76 |
2008 | 1 | 88 | 89 |
2009 | 1 | 89 | 90 |
2010 | 0 | 89 | 89 |
2011 | 0 | 124 | 124 |
2012 | 0 | 124 | 124 |
2013 | 0 | 141 | 141 |
2014 | 1 | 122 | 123 |
2015 | 1 | 138 | 139 |
2016 | 1 | 129 | 130 |
2017 | 2 | 141 | 143 |
2018 | 4 | 139 | 143 |
2019 | 1 | 165 | 166 |
2020 | 1 | 139 | 140 |
2021 | 1 | 97 | 98 |
2022 | 0 | 47 | 47 |
2023 | 0 | 52 | 52 |
2024 | 0 | 25 | 25 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas. Blood Adv. 2024 Jul 09; 8(13):3507-3518.
-
Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlations. Sci Rep. 2024 Jul 08; 14(1):15744.
-
Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy. Cells. 2024 Jun 26; 13(13).
-
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. Blood Cancer J. 2024 Jun 18; 14(1):99.
-
Olfactory Impairment and the Risk of Major Adverse Cardiovascular Outcomes in Older Adults. J Am Heart Assoc. 2024 Jun 18; 13(12):e033320.
-
The VEGF-Hypoxia Signature Is Upregulated in Basal-like Breast Tumors from Women of African Ancestry and Associated with Poor Outcomes in Breast Cancer. Clin Cancer Res. 2024 Jun 03; 30(11):2609-2618.
-
PREDICT HF: Risk stratification in advanced heart failure using novel hemodynamic parameters. Clin Cardiol. 2024 Jun; 47(6):e24277.
-
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531. Pediatr Blood Cancer. 2024 Aug; 71(8):e31089.
-
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study. Mol Cancer. 2024 May 30; 23(1):115.
-
Machine learning classifier is associated with mortality in interstitial lung disease: a retrospective validation study leveraging registry data. BMC Pulm Med. 2024 May 23; 24(1):254.